Decoding Merck & Co's Options Activity: What's the Big Picture? - Merck & Co ( NYSE:MRK )
Investors with a lot of money to spend have taken a bullish stance on Merck & Co MRK. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.
Celsius Holdings's Options Frenzy: What You Need to Know - Celsius Holdings ( NASDAQ:CELH )
Deep-pocketed investors have adopted a bullish approach towards Celsius Holdings CELH, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.
What the Options Market Tells Us About United States Steel - United States Steel ( NYSE:X )
Financial giants have made a conspicuous bearish move on United States Steel. Our analysis of options history for United States Steel X revealed 20 unusual trades. Delving into the details, we found 45% of traders were bullish, while 50% showed bearish tendencies.
NVIDIA or Palantir: Which is the Better AI Stock to Buy Now?
Both NVIDIA and Palantir hold solid positions in the AI space, but which is the better investment choice? Let's find out.
Archer Aviation Is Gaining Today -- Is the Stock a Buy?
Archer Aviation ( NYSE: ACHR ) stock is moving higher in Thursday's trading. The company's share price was up 1.2% as of 2:30 p.m. ET and had been up as much as 10% earlier in the daily session.Archer Aviation stock is climbing following recent analyst coverage on the stock.
Elon Musk Says His New AI Chatbot Is 'Scary Smart'-And Arriving in Weeks
Elon Musk claims Grok-3 has found solutions "you wouldn't even anticipate," and that the AI chatbot features an uncensored "unhinged mode." ...
Westinghouse ( WAB ) technical analysis - Westinghouse Air Brake ( NYSE:WAB )
Shares of Westinghouse are trading at support while being oversold. These dynamics could set the stage for a rally. Get real-time earnings alerts before the market moves and access expert analysis that uncovers hidden opportunities in the post-earnings chaos.
Life Science Company 10x Genomics Struggles With Profitability, Analyst Says 2025 Guidance Bakes In NIH Funding Uncertainties - 10x Genomics ( NASDAQ:TXG )
10x Genomics posted a Q4 EPS loss of $ ( 0.40 ) , missing the $ ( 0.30 ) estimate. The company's 2025 sales guidance of $610M-$630M is below the $631.14M consensus. Get access to your new suite of high-powered trading tools, including real-time stock ratings, insider trades, and ...
AppLovin's Stock Rallies After Solid Q4 Growth, Underscores Ability To Scale Profitably, Analysts Say - AppLovin ( NASDAQ:APP )
AppLovin's Q4 revenue growth accelerated to 20% Q/Q, while adj. EBITDA grew 78% Y/Y. The company's Q1 guidance reflects revenue and EBITDA growth of 29% and 59% year-on-year, respectively. Get access to your new suite of high-powered trading tools, including real-time stock ratings, insider ...
